Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity and StockBased Compensation (Details 2)

v3.22.1
Stockholders Equity and StockBased Compensation (Details 2) - Options Held [Member]
3 Months Ended
Mar. 31, 2022
$ / shares
shares
Shares, Non-vested, Beginning | shares 11,766
Shares, Granted | shares 13,514
Shares, Vested | shares (13,514)
Shares, Forfeited | shares 0
Shares, Non-vested, End Of Period | shares 11,766
Weighted Average Exercise Price, Beginning $ 5.71
Weighted Average Exercise Price, Granted 6.27
Weighted Average Exercise Price, Vested 6.27
Weighted Average Exercise Price, Forfeited 0
Weighted Average Exercise Price, End Of Period 5.71
Weighted Average Fair Value Grant Date, Beginning 4.25
Weighted Average Fair Value Grant Date, Granted 3.70
Weighted Average Fair Value Grant Date, Vested 3.70
Weighted Average Fair Value Grant Date, Forfeited 0
Weighted Average Fair Value Grant Date, End Of Period $ 4.25